Bodyweight affects mortality in an L-shape pattern in patients undergoing coronary bypass grafting.

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Future cardiology Pub Date : 2025-01-01 Epub Date: 2025-01-05 DOI:10.1080/14796678.2024.2440247
Bardia Lajevardi, Armin Talle, Mehrtash Hashemzadeh, Mohammad Reza Movahed
{"title":"Bodyweight affects mortality in an L-shape pattern in patients undergoing coronary bypass grafting.","authors":"Bardia Lajevardi, Armin Talle, Mehrtash Hashemzadeh, Mohammad Reza Movahed","doi":"10.1080/14796678.2024.2440247","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The role of body composition as a risk factor for adverse outcomesduring coronary artery bypass surgery (CABG) has been controversial. The goal of this study was to evaluate the effect of body weight on mortality in patients undergoing CABG.</p><p><strong>Method: </strong>Using a large NIS database and ICD-10 coding for different bodyweight categories, we evaluated the effect of cachexia, overweight, obesity, and morbid obesity on in-hospital mortality after CABG.  We evaluated the available database containing ICD10 coding from 2016- 2020.</p><p><strong>Results: </strong>We found that cachexia was the strongest independent predictor of in-hospital mortality whereas obesity had a protective effect. Over the 4-year sample size, patients with cachexia had nearly a 4-fold increase in mortality compared to patients with normal weight despite adjusting for age and comorbidities (4.06 CI 2.7-6.0, <i>p</i> < 0.001). Patients with overweight and Obesity had the lowest mortality (OR = 0.44 CI 0.29-0.66, OR = 0.58 CI 0.52-0.63, p, 001). However, the mortality benefit disappeared in patients with morbid obesity (OR 0.9, CI 0.84-1.03, <i>p</i> = 0.15) with a trend of higher mortality in patients with morbid obesity after multivariate adjustment.</p><p><strong>Conclusion: </strong>Cachexia is a powerful predictor for in-hospital mortality in patients undergoing CABG. Overweight and obesity have protective effect which disappears with morbid obesity.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"9-14"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812328/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2024.2440247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The role of body composition as a risk factor for adverse outcomesduring coronary artery bypass surgery (CABG) has been controversial. The goal of this study was to evaluate the effect of body weight on mortality in patients undergoing CABG.

Method: Using a large NIS database and ICD-10 coding for different bodyweight categories, we evaluated the effect of cachexia, overweight, obesity, and morbid obesity on in-hospital mortality after CABG.  We evaluated the available database containing ICD10 coding from 2016- 2020.

Results: We found that cachexia was the strongest independent predictor of in-hospital mortality whereas obesity had a protective effect. Over the 4-year sample size, patients with cachexia had nearly a 4-fold increase in mortality compared to patients with normal weight despite adjusting for age and comorbidities (4.06 CI 2.7-6.0, p < 0.001). Patients with overweight and Obesity had the lowest mortality (OR = 0.44 CI 0.29-0.66, OR = 0.58 CI 0.52-0.63, p, 001). However, the mortality benefit disappeared in patients with morbid obesity (OR 0.9, CI 0.84-1.03, p = 0.15) with a trend of higher mortality in patients with morbid obesity after multivariate adjustment.

Conclusion: Cachexia is a powerful predictor for in-hospital mortality in patients undergoing CABG. Overweight and obesity have protective effect which disappears with morbid obesity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
体重对冠状动脉旁路移植术患者死亡率的影响呈l型。
背景:体成分作为冠状动脉搭桥手术(CABG)不良结果的危险因素的作用一直存在争议。本研究的目的是评估体重对冠脉搭桥患者死亡率的影响。方法:利用大型NIS数据库和不同体重类别的ICD-10编码,我们评估了病毒质、超重、肥胖和病态肥胖对冠状动脉绕道术后住院死亡率的影响。我们评估了包含2016- 2020年ICD10编码的可用数据库。结果:我们发现恶病质是院内死亡率最强的独立预测因子,而肥胖具有保护作用。在4年的样本量中,尽管调整了年龄和合并症,但恶病质患者的死亡率比正常体重患者增加了近4倍(4.06 CI 2.7-6.0, p p = 0.15),并且在多因素调整后,病态肥胖患者的死亡率有更高的趋势。结论:恶病质是冠脉搭桥患者住院死亡率的重要预测因子。超重和肥胖具有保护作用,但随着病态肥胖而消失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Future cardiology
Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.80
自引率
5.90%
发文量
87
期刊介绍: Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.
期刊最新文献
Validation of novel predictors for early detection of cancer therapeutics-related cardiac dysfunction. From Salvador Dali and Von Gogh to BRASH: a case-based systematic literature review of digoxin induced BRASH syndrome. Reconsidering the role of beta-blockers in post-myocardial infarction patients with preserved ejection fraction. The effect of sodium-glucose co-transporter 2 inhibitors on clinical outcomes after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. The role of single-pill ACE inhibitor/ccb combination for hypertension: an Algerian view via the nominal group technique.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1